Fig. 7.
Different non-bond interactions formed for various docked complexes after the simulation period: (a) Mpro-ginsenoside Rg2, (b) Mpro-N3, (c) PLpro-saikosaponin A, (d) PLpro-VIR251, (e) RdRp-somniferine, and (f) RdRp-Remdesivir.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.